Market Report

  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood cance

  Advancement in the diagnosis of Parkinson's disease (PD) progression is propelling the growth of the levodopa market. For instance, researchers continue developing new treatments for Parkinson's disease, treatments that give real hope for people suffering from the disease. Some treatments currently being studied involve fetal cell transplantation, the use of stem cells, and gene therapy. Moreover, the development of novel formulations and drug delivery methods for levodopa is also contributing to the growth of the levodopa market . Levodopa is known by many names, including chelation therapy, L-carnitine, and nutritive adjuvant. It is a naturally occurring substance found in most tissues of the body, including the brain, heart, liver, kidney, pancreas, lungs, stomach, small intestine, and skeletal muscle tissue. This substance is often taken to treat various diseases, including Parkinson's disease and depression. As dopamine is responsible for feelings such as pleasure

  In situ hybridization (IHT) is a form of DNA hybridization in which the genetic material of an unknown cell is inserted into the living cell without initiating the creation of a new embryo. IHT may be used for the research and development of specific cells but also may be used to insert DNA from an unknown source into a patient's body to develop the potential for disease diagnosis. This process has enabled doctors to successfully use in vitro fertilization (IVF) to successfully treat infertility problems in many patients. It has also enabled scientists to create hair, eye, and tissue samples from live patients in clinical trials for testing drugs and possible treatments. Other uses for in situ hybridization may also include the development of transplants from genetically identical twins, the cloning of animals and insects, and the successful transplant of tissue into a human body that is damaged by disease. In recent times, there has been an increasing incidence of cancer in th

  Hernia is one of the common conditions affecting a large percentage of population worldwide. Over one million hernia repair surgeries are performed each year, many of which use hernia mesh. Hernia mesh, or surgical mesh, is a medical device used to support and hold organs in place after surgery, attached to the area surrounding the hernia with glue, staples, or stitches. Hernia mesh are of three types, such as biologic, composite, or synthetic. Hernia mesh devices are surgical meshes that are used to provide additional support to weak/damaged tissue. Growth of the hernia mesh devices market is mainly driven by the Increasing incidence of hernia. According to the Food and Drug Administration (FDA), every year, more than one million hernia repairs are performed in the United States. Around 800,000 are to repair inguinal hernias and the rest are for other types of hernias. Hiatal hernias, femoral hernia, umbilical hernia, abdominal hernia, and inguinal hernia are some the common types

  Healthcare EDI or Electronic Data Interchange was conceptualized to build a database that would enable shared access to health information from multiple locations. It makes it possible to exchange the same data between the different entities involved in the care of patients such as doctors, nurses, and other health care providers. In essence, EDI breaks down the physical and financial boundaries that are set between the various parties involved in a health care organization. The adoption of healthcare EDI solutions has witnessed massive growth in developed economies such as the U.S. and Canada. This is due to the fact that there is high demand for innovative IT solutions to streamline workflows combined with increasing regulatory requirements related to patient safety. As time changes, healthcare organizations are adapting to newer technologies, in order to cater to changing demands. Big data adoption is one of those advanced technologies that has witnessed rising adoption among he

  Endometriosis is a chronic disease in which tissue that normally lines the uterus grows outside the uterus. It affects around five to ten per cent women of childbearing age. Endometriosis most commonly involves ovaries, fallopian tubes, and the tissue lining the pelvis. The most common symptoms include pain during urination, pain after intercourse in pelvic area, pain in lower back during menstrual period, pain in pelvic area before menstrual cycle, excessive bleeding between periods, nausea during menstrual cycle, diarrhea, fatigue, and constipation. Effective treatments, such as hormones and excision surgery, are available. The endometriosis treatment market growth is mainly driven by the increasing prevalence of endometriosis. According to the Endometriosis Foundation of America, endometriosis affects around 200 million women worldwide and about 1 out of every 10 women in the United States. It affects women mostly in their reproductive years and can even affect adolescents who